Pharmaceutical companies, including Pfizer and Johnson & Johnson, are under pressure from governments and their own shareholders to ramp up access to COVID-19 vaccines as global distribution of the shots remains wildly unequal. The U.S. reportedly bought enough doses to fully vaccinate over 700 million people, more than twice its population. Meanwhile, nearly a dozen countries in Africa and elsewhere are […] The post Vaccine makers pressed by.